FULBRECA 250MG INJECTION

About FULBRECA 250MG INJECTION

Fulbreca 250MG Injection contains fulvestrant 250mg/5ml. It blocks and breaks down the oestrogen receptor that hormone-sensitive breast cancer depends on, which is why it is classed as an oestrogen receptor degrader (hormone therapy). Specialists use it for hormone receptor-positive advanced breast cancer in women after menopause, alone or with a CDK4/6 inhibitor. During treatment expect regular checks such as injection-site reactions and liver tests. Made by RPG Life Sciences; pack size 1 vial (5ml). MRP Rs 5,491 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.